24 unknown. 24 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Unknown 24 |
| Phase 2 | 7 | Unknown 7 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Terbinafine and Itraconazole Terbinafine Tablets, Itraconazole - Tinea Corporis, Tinea Cruris | Phase 2 / Phase 3 | Unknown | Dhaka Medical College | 150 | 2023-05-01 | 2023-05-31 |
| Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3 MAT2203, Amphotericin B - Cryptococcal Meningitis | Phase 3 | Unknown | Matinas BioPharma Nanotechnologies, Inc. | 270 | 2023-01-01 | 2022-09-15 |
| A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) MOB015B, Vehicle (Placebo Comparator) - Onychomycosis | Phase 3 | Unknown | Moberg Pharma AB | 350 | 2022-05-09 | 2024-06-26 |
| Efficacy of Intralesional PRP in Treatment of Onychomycosis intralesional platelet rich plasma, Oral terbinafine - Platelet Rich Plasma | Phase 3 | Unknown | Sohag University | 75 | 2021-12-01 | 2021-11-22 |
| A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis SHR8008, Fluconazole - Recurrent Vulvovaginal Candidiasis | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 196 | 2021-09-14 | 2021-10-12 |
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection Posaconazole 100 MG [Noxafil], Posaconazole 40 MG/ML - Cystic Fibrosis, Aspergillosis | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 135 | 2021-04-22 | 2021-07-19 |
| Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 Darunavir and Cobicistat - Pneumonia, Pneumocystis, Coronavirus | Phase 3 | Unknown | Shanghai Public Health Clinical Center | 30 | 2020-01-30 | 2020-04-13 |
| AmB Dose for Cryptococcal Meningitis Amphotericin B, Flucytosine - Cryptococcal Meningitis, HIV Infections | Phase 3 | Unknown | Shanghai Public Health Clinical Center | 40 | 2020-01-02 | 2019-10-29 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis caspofungin antifungal therapy, placebo - ICU Yeast Intra-abdominal Infection | Phase 3 | Unknown | Centre Hospitalier Universitaire, Amiens | 448 | 2019-01-01 | 2024-07-10 |
| Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Ketoconazole, Terconazole - Vaginal Candidiasis | Phase 3 | Unknown | Assiut University | 69 | 2018-04-01 | 2018-03-22 |
| Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis Nailner 2 in 1, Ciclopirox 8% - Onychomycosis | Phase 3 | Unknown | MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA | 46 | 2017-04-01 | 2017-03-31 |
| Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients Methylprednisolone, Placebo - Pneumocystis, Steroids | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 222 | 2017-02-15 | 2020-10-06 |
| Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops - Infection, Fungal | Phase 2 / Phase 3 | Unknown | L.V. Prasad Eye Institute | 55 | 2017-01-01 | 2017-07-26 |
| Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Prevention & Control | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 80 | 2012-08-01 | 2012-12-11 |
| Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa Fluconazole, Flucytosine, lumbar punctures - Cryptococcal Meningitis, HIV | Phase 2 / Phase 3 | Unknown | ANRS, Emerging Infectious Diseases | 41 | 2012-05-01 | 2016-07-12 |
| Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections Clotrimazole - Fungal Infections, Tinea Pedis | Phase 3 | Unknown | Laboratório Teuto Brasileiro S/A | 90 | 2012-04-01 | 2012-04-12 |
| Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia Interferon-gamma, Recombinant - Candidemia | Phase 3 | Unknown | Radboud University Medical Center | 20 | 2011-01-01 | 2012-02-14 |
| Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis SPK-843 - Cryptococcosis or Aspergillosis Infections | Phase 3 | Unknown | Proaparts srl | 10 | 2010-05-01 | 2011-06-08 |
| TDT 067 Onychomycosis Study TDT067, Placebo, Transfersome - Onychomycosis | Phase 3 | Unknown | Celtic Pharma Development Services | 738 | 2010-04-01 | 2012-08-01 |
Showing 20 of 24. Sign in to see all of them.
Onychomycosis (5) · Candidiasis, Vulvovaginal (3) · Meningitis, Cryptococcal (3) · Pneumonia, Pneumocystis (3) · Tinea (3) · Candidiasis (2) · HIV Infections (2) · Tinea Cruris (2) · Tinea Pedis (2) · Aspergillosis (1) · COVID-19 (1) · Candidemia (1) · Choroidal Neovascularization (1) · Coronavirus Infections (1)
Bacterial Infections and Mycoses (24) · Infections (24) · Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Dermatomycoses (7) · Skin Diseases, Infectious (7) · Genital Diseases (6) · Urogenital Diseases (6) · Nail Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Tinea (5) · Candidiasis (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4)
Amphotericin B (3) · Fluconazole (3) · Terbinafine (3) · Flucytosine (2) · Ketoconazole (2) · Suspensions (2) · Antiretroviral Therapy, Highly Active (1) · Clindamycin (1) · Clotrimazole (1) · Interferon-gamma (1) · Itraconazole (1) · Methylprednisolone (1) · Ophthalmic Solutions (1) · SPA S 843 (1) · Spinal Puncture (1)
Shanghai Public Health Clinical Center (2) · ANRS, Emerging Infectious Diseases (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · Bambino Gesù Hospital and Research Institute (1) · Celtic Pharma Development Services (1) · Centre Hospitalier Universitaire, Amiens (1) · Dhaka Medical College (1) · Jamaica Hospital Medical Center (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · L.V. Prasad Eye Institute (1) · Laboratório Teuto Brasileiro S/A (1) · MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA (1) · Matinas BioPharma Nanotechnologies, Inc. (1) · Moberg Pharma AB (1)
China (4) · United States (4) · France (3) · Brazil (2) · Italy (2) · Netherlands (2) · Austria (1) · Burundi (1) · Canada (1) · Czechia (1) · Côte d’Ivoire (1) · Egypt (1) · Germany (1) · Greece (1) · India (1)
Adilia Warris, Prof (1) · Corine Delsing, MD (1) · David B Meya, MBChB (1) · David R Boulware, MD (1) · Eduardo Tschen, MD (1) · Elie Azoulay, MD PHD (1) · Fengchun Zhang, MD (1) · Francesco Blasi, MD (1) · Herbert Kiss, Prof. (1) · Jeffrey Weinberg, MD (1) · Luigi Allegra, Ph.D. (1) · Mihai Netea, MD PhD (1)
PMID 15232472, PMID 19506188, PMID 24669841, PMID 32671131, PMID 40652952, PMID 41365527, PMID 41845293, PMID 42558999
2009 (1), 2016 (1), 2019 (1)